11-6608029-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006284.4(TAF10):c.*2893A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000831 in 1,613,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000080 ( 0 hom. )
Consequence
TAF10
NM_006284.4 3_prime_UTR
NM_006284.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.760
Publications
0 publications found
Genes affected
TAF10 (HGNC:11543): (TATA-box binding protein associated factor 10) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the small subunits of TFIID that is associated with a subset of TFIID complexes. Studies with human and mammalian cells have shown that this subunit is required for transcriptional activation by the estrogen receptor, for progression through the cell cycle, and may also be required for certain cellular differentiation programs. [provided by RefSeq, Jul 2008]
ILK (HGNC:6040): (integrin linked kinase) This gene encodes a protein with a kinase-like domain and four ankyrin-like repeats. The encoded protein associates at the cell membrane with the cytoplasmic domain of beta integrins, where it regulates integrin-mediated signal transduction. Activity of this protein is important in the epithelial to mesenchymal transition, and over-expression of this gene is implicated in tumor growth and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
ILK Gene-Disease associations (from GenCC):
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 11-6608029-T-C is Benign according to our data. Variant chr11-6608029-T-C is described in ClinVar as [Benign]. Clinvar id is 1601475.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 17 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152136Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
17
AN:
152136
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000175 AC: 44AN: 251354 AF XY: 0.000155 show subpopulations
GnomAD2 exomes
AF:
AC:
44
AN:
251354
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000801 AC: 117AN: 1461298Hom.: 0 Cov.: 31 AF XY: 0.0000715 AC XY: 52AN XY: 726992 show subpopulations
GnomAD4 exome
AF:
AC:
117
AN:
1461298
Hom.:
Cov.:
31
AF XY:
AC XY:
52
AN XY:
726992
show subpopulations
African (AFR)
AF:
AC:
8
AN:
33462
American (AMR)
AF:
AC:
7
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
27
AN:
26134
East Asian (EAS)
AF:
AC:
12
AN:
39698
South Asian (SAS)
AF:
AC:
3
AN:
86228
European-Finnish (FIN)
AF:
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
AC:
14
AN:
5414
European-Non Finnish (NFE)
AF:
AC:
29
AN:
1111904
Other (OTH)
AF:
AC:
17
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000112 AC: 17AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74320 show subpopulations
GnomAD4 genome
AF:
AC:
17
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74320
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41428
American (AMR)
AF:
AC:
2
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
6
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
AC:
1
AN:
316
European-Non Finnish (NFE)
AF:
AC:
4
AN:
68022
Other (OTH)
AF:
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Primary familial hypertrophic cardiomyopathy Benign:1
Nov 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.